Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Balder announces results regarding tender offer on outstanding hybrid capital securities

Fastighets AB Balder (publ), via its subsidiary Balder Invest AB, has today announced the results of its invitation to holders of the hybrid capital securities, EUR 500 million 5.25 year non-call, first reset date 2 June 2026 (ISIN: XS2305362951) to tender their hybrid capital securities for purchase by Balder Invest AB for cash up to an aggregate principal amount of EUR 100 million (the “Tender Offer”). The results are as follows: ISIN First reset date Issued (EUR) Repurchased (EUR)XS2305362951 02-Jun-26 500.000.000 100.000.000 The expected Settlement Date

Jonas Sohlman appointed as new CEO for Intervacc

Stockholm, February 28, 2024 - The Board of Directors for Intervacc AB (publ) announces that acting CEO Jonas Sohlman has been appointed as the new CEO of Intervacc AB and assumes the position immediately. The recruitment process that the previous board initiated has continued and now resulted in the appointment of Jonas Sohlman as the new CEO. Jonas has been working as the acting CEO since last August and assumes the role of CEO starting today. “As the company finds itself in a crucial phase with many opportunities but also challenges, a well-informed and solution-oriented leader

BioStock: Evaxion partners with MSD for vaccine development

Last fall, Evaxion Biotech announced entering a collaboration with a leading pharma company for the development of a vaccine against a bacterial pathogen causing severe healthcare issues. Now, we know that the partner is MSD. According to Evaxion, the initial phases of the collaboration have been successful. BioStock reached out to Evaxion’s CEO, Christian Kanstrup, to learn more.Read the interview with Christian Kanstrup at biostock.se: Evaxion partners with MSD for vaccine development - BioStock 

Carbiotix achieves IVDR and CE marked status for LinkGut testing kit

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the Company has received IVDR (In Vitro Diagnostic Regulation) Class A and CE marked status for its LinkGut microbiome testing kit. This represents a key milestone in the development of the testing kit, fulfilling the requirements of several existing and potential customers, and opens up the LinkGut service to the much larger and faster growing clinical study and research segment of the microbiome sequencing services market.Erik Deaner, CEO of Carbiotix, comments:“I am extremely pleased to announce that our LinkGut

Cereno Scientific to present at Life Science-dagen in Gothenburg on March 6, 2024

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will present at the event Life Science-dagen, organized by Finwire and Corporate Financing Fyrstad on Wednesday, March 6, 2024, in Gothenburg.Sten R. Sörensen, Chief Executive Officer (CEO) at Cereno, will participate in the event and give a 20-minute presentation of the company followed by a 10-minute Q&A at 08:45–09:15. The event is held at Wallenberg Conference Centre, Medicinaregatan 20, in Gothenburg, and is live

Inhalation Sciences AB (publ) releases Q4 / YE Report

(Stockholm, Sweden, 28 February 2024) Inhalation Sciences AB announces that its Q4 / Year End Report for 2023 is now available on the company’s website.To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/ CEO statement 2023 was another year when we continued to capture new market shares and successfully deliver on our strategic goals. Over the past three years, revenue has increased steadily by 29% from 2021 to 2022 and now by 49% from 2022 to 2023. At the same time, we have also significantly improved our operating profit at a similar

Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024

Announcement no. 6/2024 28 February 2024 Final agenda and proposals for the Annual General Meeting 13 March 2024 Enclosed is the final agenda and proposals for Össur hf.'s Annual General Meeting to be held on Wednesday 13 March 2024 at 9:00 AM (GMT) at the Company’s headquarters at Grjótháls 5, Reykjavík, Iceland. No changes have been made to the previously announced agenda and proposals. Further information David Hreidarsson, VP of Investor Relations, IR@ossur.com, +354 661 8225 Össur press releases by e-mail If you wish to receive Össur press releases by e-mail,

Quickbit announces a financial update

Today, Quickbit announces that net sales in the third quarter are expected to double from the last reported level of 8.9 mEUR, maintaining a gross margin of over 4%.In the most recently reported interim report for the second quarter of '23/24, Quickbit reported a doubling of net sales from 4.4 mEUR to 8.9 mEUR compared to the first quarter. Quickbit now announces that net sales for the third quarter ‘23/24 are expected to double compared to the second quarter, with maintained gross margin.  At the same time, Quickbit and Paysecure have agreed on an interest-free convertible bridge

DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results

COPENHAGEN, Denmark, 28 February 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the fourth quarter of 2023 (“Q4-2023”). The Q4-2023 report is available as an attached document to this press release and at www.dancann.com.Summary: Group Key Figures Q4-2023 DKK 1,000 01/01/23 01/01/22 01/10/23 01/10/22 01/01/22 –31/12/23 –31/12/22 – 31/12/23 – 31/12/22 – 31/12/22 Net sales: 6,073 5,707 1,611 2,101

Interim report Q4, 2023

Fourth quarter · Net sales amounted to SEK 3.7 (14.2*) million · EBITDA amounted to SEK -1.5 (-4.0) million · EBIT amounted to SEK -14.4** (-27.7) million · EBT amounted to SEK -16.0 (-27.5) million · Cloud Explorers Solutions AS, a Norwegian subsidiary of SpectrumOne AB, announces the signing of a formal Partnership Agreement with Tietoevry Significant events after the reporting period · SpectrumOne AB appoints Stephen Karl Ranson as the new Chief Executive Officer Full year · Net sales amounted to SEK 23.3 (74.0*)  million · EBITDA amounted to SEK -15.

How to Fix Up The Exterior of An Older Period Property

If you live in a period property, it is likely that you purchased the property for specific reasons - usually due to the home's appearance. This means you will want to protect some of the key period characteristics when performing renovations on the home. This may include things like the external sash windows, external brickwork, and exterior doors.   [A house with trees and a fence Description automatically generated with medium confidence]   Certain distinguishing features can make a period home very special. Period homes are also often seen as a very sought-after investment.

Foxway Holding AB (publ) Q4 2023 Interim report

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO U.S. PERSONS OR IN OR INTO ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL.Foxway Holding AB (publ) has today published its Q4 2023 Interim report. The report is available on the company’s website.  “2023 was another eventful year for Foxway as we continued our expansion and the transition of the tech industry toward the circular economy. During the year, we have seen a strong growth in the Recommerce Mobile segment driven by our

Swedbank adopts Poseidon Principles for carbon footprint reporting of shipping portfolio

Swedbank has signed the Poseidon Principles, a global framework for integrating climate considerations into lending decisions within ship finance. By signing, Swedbank enhances its ability to support and influence the continued decarbonisation efforts of the shipping industry.The Poseidon Principles provide a standardised methodology for data collection and reporting of emissions from banks’ shipping portfolios, with the overall ambition of supporting and facilitating the decarbonisation of the shipping industry.  “We are happy to have signed the Poseidon Principles, the main reference

Höegh LNG: Interim results for the quarter and year ended 31 December 2023

Hamilton, Bermuda, 28 February 2024 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its interim financial results for the quarter and year ended 31 December 2023. The group reported an EBITDA of USD 78 million for the fourth quarter of 2023, compared to USD 89 million for the preceding quarter. In the fourth quarter, Höegh LNG completed the refinancing of Hoegh Gannet and entered into partnership with VTTI B.V to develop a new energy terminal in or near the port of Vlissingen in the Netherlands. In addition, the charterer of Höegh Grace waived its termination option in 2026, which

Norconsult acquires consulting company Concreto AS

Sandvika, 28 February (OSE: NORCO): Norconsult Norge AS, a subsidiary of Norconsult ASA, has acquired the Oslo-based planning and analysis company Concreto AS. The company operates mainly within buildings, infrastructure and urban planning. Concreto's services primarily focus on economic analysis as a basis for decision-making by project owners in the early phases of projects. These services encompass early phase project consulting, concept development and project management, quality assurance, cost estimation, project improvement, cost-benefit and risk analysis, and dispute handling.

MindArk Year-end Report 2023

MindArk PE AB (publ) ("MindArk", the "Company") hereby announces that the Company's year-end report for 2023 and interim report for Q4 2023 have been published.Comment from CEO Henrik Nel Jerkrot: "As we bring 2023 to a close, it is gratifying to present a strong end to the year. The reorganization we carried out in Q2 and Q3 has translated into a strong boost in profitability in Q4. We can also note that our universe continues to grow. In the fourth quarter, the revenue increase attributable to Entropia Universe exceeded 27% compared to the same period last year." Reporting period

SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform

STOCKHOLM, SWEDEN, - February 28, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Skinobs, a leading global platform connecting researchers with the tools they need for their cosmetic and medical research. Through this partnership, SciBase will now offer Nevisense for assessing skin barrier function within cosmetic testing on the Skinobs platform.Through the Skinobs platform, researchers can easily find information on who is conducting what tests in the field of

BPC Instruments reports results for the year 2023

BPC Instruments (“BPC” or “the Company”) hereby publishes the year-end report for the year 2023. The year-end report is available as an attached file to this release and on the Company’s website (www.bpcinstruments.com/finanical-reports ). Below is a summary of the report.CEO Jing Liu comments: “It brings me great pleasure to present a comprehensive overview of the year-end report for the Q4 period & full year of 2023, marking the conclusion of what can only be described as a historic fiscal year for BPC Instruments. As we enter a promising

Tradedoubler Year-End Report January – December 2023

The fourth quarter, October - December 2023 · Total revenue amounted to SEK 575 M (464) an increase of 24% compared to the same period last year. · Gross profit was SEK 118 M (102) an increase of 16%. Gross margin was 20.5% (22.0).  · Operating costs excluding depreciation and adjusted for change related items were SEK -88 M (-76), an increase of 17%. · EBITDA amounted to SEK 29 M (26). Adjusted for change related items, EBITDA was SEK 30 M (26). · Investments in tangible and intangible fixed assets, mainly related to product development, were SEK 10 M (9). · Cash flow

Essity’s Annual Report for 2023

Hygiene and health company Essity is today publishing its Annual Report for 2023 on essity.com .“We leave an eventful year behind us in which we have focused on increasing profitability and created a stable platform for profitable growth. Through innovation, restructuring, efficiency improvements and price increases, we achieved an adjusted profit of SEK 18.9bn – the highest profit ever – while also increasing net sales to SEK 147bn. We have undertaken to accept the offer in respect of all shares in Vinda. It is a very attractive offer for Essity and our shareholders

Transaction in Own Shares

    28 February 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |27/02/2024|+----------------------------------------------------------

Peab rebuilds school in Lund

Peab has been commissioned to build a school in Lund. The customer is Lundafastigheter and the contract is worth SEK 139 million.The property is located in the southeast section of Lund in the Vipelyckan area. For years the school has housed Vipan High School’s restaurant and food program which will now get a top modern teaching commercial kitchen and bakery. The total surface of the renovation is almost 4,200 m2 gross area. “We’re pleased and proud to be part of creating good learning conditions for the students in Lund through this continued collaboration with Lundafastigheter. As a

There are no items matching the current filter
There are no more items matching the current filter
Back to top